Rotavirus vaccine 'safe for under twos'
A vaccine against severe rotavirus gastroenteritis is safe and effective if used during the first two years of life, according to a study by researchers from Singapore and China.
10,700 healthy infants were enrolled to receive either the Rotarix vaccine or placebo.
From two week to two years of age vaccine efficacy was 96.1% against severe rotavirus gastroenteritis. No cases of intestinal damage were recorded within 31 days of vaccination.
The research follows reports that rotavirus vaccination could increase the risk of intussusception.
Vaccine, published online August 11 2009